Effectiveness of interventions for hypertension care in the community – a meta-analysis of controlled studies in China

[1]  M. Prince,et al.  Hypertension prevalence, awareness, treatment and control among older people in Latin America, India and China: a 10/66 cross-sectional population-based survey , 2012, Journal of hypertension.

[2]  P. Marquez,et al.  Toward a healthy and harmonious life in China : stemming the rising tide of non-communicable diseases , 2011 .

[3]  Y. Lee,et al.  Prevalence, awareness, treatment, control, and risk factors associated with hypertension in urban adults from 33 communities of China: the CHPSNE study , 2011, Journal of hypertension.

[4]  V. Fuster,et al.  Promoting global cardiovascular health ensuring access to essential cardiovascular medicines in low- and middle-income countries. , 2011, Journal of the American College of Cardiology.

[5]  Gretchen A. Stevens,et al.  National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants , 2011, The Lancet.

[6]  Michele Tarsilla.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[7]  Bridget B. Kelly,et al.  Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health , 2010 .

[8]  Mohammed F. Faramawi,et al.  Cardiovascular risk management and its impact on hypertension control in primary care in low-resource settings: a cluster-randomized trial. , 2010, Bulletin of the World Health Organization.

[9]  Tom Fahey,et al.  Interventions used to improve control of blood pressure in patients with hypertension. , 2010, The Cochrane database of systematic reviews.

[10]  F. Song,et al.  Dissemination and publication of research findings: an updated review of related biases. , 2010, Health technology assessment.

[11]  K. Reynolds,et al.  Premature deaths attributable to blood pressure in China: a prospective cohort study , 2009, The Lancet.

[12]  D. Moher,et al.  Randomized trials published in some Chinese journals: how many are randomized? , 2009, Trials.

[13]  N J Wald,et al.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009, BMJ : British Medical Journal.

[14]  N. Lunet,et al.  Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries , 2009, Journal of hypertension.

[15]  M. Woodward,et al.  Prevalence, Awareness, Treatment, and Control of Hypertension in China: Data from the China National Nutrition and Health Survey 2002 , 2008, Circulation.

[16]  Stephen Jan,et al.  Global inequalities in access to cardiovascular health care: our greatest challenge. , 2008, Journal of the American College of Cardiology.

[17]  Gerta Rücker,et al.  Bmc Medical Research Methodology Open Access Undue Reliance on I 2 in Assessing Heterogeneity May Mislead , 2022 .

[18]  Julian P T Higgins,et al.  Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. , 2008, International journal of epidemiology.

[19]  R. Collins,et al.  Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.

[20]  N. Chaturvedi,et al.  Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trial , 2007, BMJ : British Medical Journal.

[21]  Vandana Sundaram,et al.  Quality Improvement Strategies for Hypertension Management: A Systematic Review , 2006, Medical care.

[22]  A. Sutton,et al.  Comparison of two methods to detect publication bias in meta-analysis. , 2006, JAMA.

[23]  A. Hrõbjartsson,et al.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.

[24]  L. Li,et al.  [Meta-analysis on the effectiveness of community-based multiple risk factor interventions for hypertension prevention]. , 2000, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[25]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[26]  Xi-gui Wu,et al.  Prevalence of hypertension and its trends in Chinese populations. , 1995, International journal of cardiology.

[27]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[28]  N. Freemantle,et al.  Are randomized trials conducted in China or India biased? A comparative empirical analysis. , 2011, Journal of clinical epidemiology.

[29]  J. Higgins.  Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .

[30]  Zhou Ying-qin.  Effect of Community Nursing Intervention on Hypertension in Elders:A Meta-analysis , 2010 .

[31]  W. Elliott.  Community-Based Interventions to Promote Blood Pressure Control in a Developing Country: A Cluster Randomized Trial , 2010 .

[32]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[33]  M. Law.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009 .

[34]  M. Young,et al.  Health services research , 2008, Journal of General Internal Medicine.